VESALIO

Thanks to #NeVa users for sharing the power of our device in this fun and insightful video! Special thanks for discussing the Drop Zone technology for tackling tough #thrombectomy cases. #DoTheDropZone for First Pass Success! youtu.be/cAFWP5MbIyI

Thanks to everyone who stopped by the Vesalio booth at #TCT2026. It was exciting to see the international and U.S. communities come together to put evidence and experience to work. We enjoyed sharing #enVast and the NATURE RCT findings on large thrombus burden. #DoTheDropZone

Is it time to rethink your first move in primary PCI? Visit us at #TCT2026 & learn about the NATURE RCT showing a 26% smaller infarct size in the #enVast arm, compared to conventional PCI in #STEMI patients presenting w/ LTB. #DoTheDropZone Ref jacc.org/doi/10.1016/j.jacc.…

Every M1nute counts. Today, #WorldStrokeDay, we’re proud to join #SLICEWorldwide, a free online stroke course for young physicians. #NeVa is featured in several videos with Dr. Costalat. Thanks to all who #ActFAST. REGISTER masterandfellow.com/slice/ww #LeaveNoClotBehind @slice_inr

How are you treating patients w/ large thrombus burden (LTB)? Visit us at TCT & learn about the NATURE randomized controlled trial showing a 26% smaller infarct size in the #enVast arm than in conventional PCI in #STEMI patients presenting w/ #LTB. Ref doi.org/10.1016/j.jacc.2026.…

What does it take to leave no clot behind? We're at the Flow to the Toe CME Conference today, talking about #pVasc® & how Drop Zone® technology helps address challenging peripheral arterial thrombus. Come say hello & bring your toughest cases. #LeaveNoClotBehind @VascularInstitu

Large thrombus burden. Varying clot morphologies. Are you satisfied with your options? Come see #enVast at #MayoCAD, Oct 23-25. enVast is FDA-cleared & CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety & warnings.

Congratulations to Dr Qazi Jehanzeb & team at @tawamseha UAE for this beautiful result w/ #pVasc. Thanks Priya Bhojwani for sharing. CLICK lnkd.in/p/gA5SM7vX #DoTheDropZone pVasc is FDA-cleared, not CE-marked. See vesalio.com/pvasc-ifu/ for indications, safety & warnings.

We welcome Daniel Davis! He’s joining Vesalio’s Board of Directors and serving as Advisor to our CEO, Steve Rybka. 25+ years building thrombectomy businesses at Penumbra and Imperative Care. Read the full release: vesalio.com/vesalio-appoints… #LeaveNoClotBehind

Thrombosis can strike anywhere, with devastating consequences. 1 in 4 deaths worldwide are associated with thrombosis. On #WorldThrombosisDay, we thank the physicians who remove clots, restore blood flow and give patients a chance at better outcomes. #WTDay26 #LeaveNoClotBehind

Thank you to everyone who joined us at #NEURORAD2026! Special thanks to Prof. Stefan Rath for presenting on #NeVaVS and to congress presidents: Dr. Kaiser, Dr. Schwab, & Dr. Wenger-Alakmeh for a great meeting! #DoTheDropZone #NeVa @daniel_kaiserMD @Roland_K_Schwab @DTangun

NeVa on WFITN stage! 🎉 🗓️ Mon Oct 12, 16:30-17:30 📍 AS-IS-4 🎤 First Multicenter Procedural Experience with the NeVa 3x17mm Stent Retriever for Acute Ischemic Stroke in Anterior Circulation Occlusions 👤 Prof Dr Johannes Pfaff Thanks to Prof Pfaff, #NeVa pilot centers & #WFITN

Today at #NEURORAD2026! 👉 JOIN US: 🗓️ 8-9:30AM 📍 Zagreb A 🎤 Non-obstructive vessel dilation using the NeVa VS device to prevent disease deterioration in aSAH patients with symptomatic cerebral vasospasm 👤Prof Dr Stefan Rath #DoTheDropZone #NeVa #NeVaNET #NeVaVS @DTangun

#DoTheDropZone at #NEURORAD2026! 👉 JOIN US: 🗓️ THU, Oct 8, 8-9:30AM 📍 Zagreb A 🎤 Non-obstructive vessel dilation using the NeVa VS device to prevent disease deterioration in aSAH patients with symptomatic cerebral vasospasm 👤Prof Dr Stefan Rath #NeVa #NeVaNET #NeVaVS @DTangun

We're at GeNI Congress in Bilbao, Spain, Sept 30-Oct 2! Drop by to talk #NeVa, #NeVaNET, and #NeVaVS, our neurothrombectomy and vasospasm portfolio. Come partner with us! @Geni_NRI #GeNI2026 #DoTheDropZone

Vesalio is at #DGKHerztage in Hamburg, Sept 26-28, with #enVast: the first & only FDA-cleared & CE-marked coronary clot retriever. NATURE trial data: 25.8% reduction in infarct size compared to current standard of care. Let's discuss tackling large thrombus burden. #DoTheDropZone

Challenging clot? Drop into the Drop Zone at @CorsVascAtShore, Sept 25-27. pVasc® is engineered with Drop Zone™ technology to trap and remove challenging peripheral arterial thrombus. Stop by and let's talk about how to simplify your clot removal. #DoTheDropZone #CORSVASC

Vesalio is onsite at #ISEVS2026 in Houston with #enVast, our coronary clot retriever. #DoTheDropZone enVast is FDA-cleared & CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety & warnings.

🚀 Vesalio is hiring a Supply Chain Analyst to join our Operations team! Help advance the treatment of thromboembolic vascular disease with a dynamic, fast-growing company. 🌟 Apply: vesalio.com/about/careers/su… #MedicalDevices #Hiring #DoTheDropZone

🚀 Vesalio just added Chicago to our search for U.S. Territory Managers! Also hiring in Phoenix, Dallas, Kansas City/St. Louis, and Boston. 🌟 Apply: vesalio.com/about/careers/us… #MedicalDevices #TerritoryManager #Hiring #DoTheDropZone

Coverage from ADVFN UK on the NATURE study following its presentation at #ESC2026. #NATUREStudy➡️uk.advfn.com/stock-market/sh… enVast is FDA-cleared and CE-marked. See vesalio.com/envast-ifu-fda or vesalio.com/envast-ifu-ce depending on your region, for indications, safety and warnings.